CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Treatment of chronic hepatitis C with PegIFN-alfa2b and ribavirin: Outcome for migrants from GUS countries is associated with higher SVR-rates compared to German patients within a large German multicentric observational study
DOI 10.1055/s-0030-1263892
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS Mauss, E Zehnter, MP Manns, G Teuber, T Dahhan, U Meyer, T Witthöft, B Möller, N Dikopoulos, J Brack, M Bilzer, G Tossing, D Hüppe
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2010
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: A combination of pegylated interferon-alfa (PegIFN-alfa) plus ribavirin (RBV) is the current standard of care for treatment of chronic hepatitis C. Within a German multicentric observational study the largest group of migrants came from Ex-USSR countries. As higher SVR-rates have been observed in the group of GUS-migrants compared to German patients (Mauss et al, Abstract GASL 2010), we investigated if this fi…
Zitieren
Zitierempfehlung
S Mauss, E Zehnter, MP Manns, G Teuber, T Dahhan, U Meyer, T Witthöft, B Möller, N Dikopoulos, J Brack, M Bilzer, G Tossing, D Hüppe (2010) Treatment of chronic hepatitis C with PegIFN-alfa2b and ribavirin: Outcome for migrants from GUS countries is associated with higher SVR-rates compared to German patients within a large German multicentric observational study. Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-0030-1263892
Mit CareLit weiterarbeiten